Treatment with carbamazepine, everolimus, or rapamycin reduced HIV-1 replication in infected ex vivo CD4+ T cells, while only therapeutic rapamycin administration intervened in ongoing HIV-1 infection in CD11c+ DCs. The gene discussed is CD4; the disease is HIV-1 infection.